SANDU PHARMACEUTICALS LTD. Share Price

BSE: 524703

Pharmaceuticals

S Cap

₹ 37.74

-₹0.02 (-0.05%)

Last updated 22 Sep, 2026, 15:29 IST

0.05% down today

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 4.35% YoY

Latest Earning

Net Profit TrendUp by 6.16% YoY

Latest Earning

Revenue TrendDown by 23.11% QoQ

Stock Performance

OutperformingBeat Nifty by 2.18 % in last 1 month

SANDU PHARMACEUTICALS LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,07,423-₹92,577 (-18.52%)

3 Year

₹2,54,791-₹2,45,209 (-49.04%)

5 Year

₹3,76,471-₹1,23,529 (-24.71%)

Note: Past profits do not guarantee future returns.

₹30.21₹45.31

Circuit Low

Circuit High

₹30.00₹50.00

52-Week Low

52-Week High

Circuit

₹30.21

₹45.31

52-week

₹30.00

₹50.00

About SANDU PHARMACEUTICALS LTD.

ISIN

INE751D01014

Sector Market Cap

₹ 36.15 Cr

Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.

SANDU PHARMACEUTICALS LTD. Financial Highlights

Revenue: SANDU PHARMACEUTICALS LTD. reported revenue of ₹67.36 crore in FY25 vs ₹67.70 crore in FY24. It showed a decrease of 0.50% on a yearly basis.
Operating Profit: SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹2.16 crore in FY25 vs ₹2.07 crore in FY24. It showed an increase of 4.35% on a year-on-year basis.
Net Profit: SANDU PHARMACEUTICALS LTD. reported a net profit of ₹1.55 crore in FY25 vs ₹1.46 crore in FY24. It showed an increase of 6.16% on a yearly basis.

SANDU PHARMACEUTICALS LTD. Quarterly Result Highlights

SANDU PHARMACEUTICALS LTD. reported revenue of ₹14.14 crore in Mar 2025, compared with ₹18.39 crore in Dec 2024, representing a decrease of 23.11% on a quarter-on-quarter (QoQ) basis.
SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹0.34 crore in Mar 2025, compared with ₹0.80 crore in Dec 2024, representing a decrease of 57.50% on a quarter-on-quarter (QoQ) basis.
SANDU PHARMACEUTICALS LTD. reported a profit of ₹0.33 crore in Mar 2025, compared with ₹0.56 crore in Dec 2024, reflecting a decrease of 41.07% on a QoQ basis.
The earnings per share (EPS) of SANDU PHARMACEUTICALS LTD. stood at ₹1.60 during Mar 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more

Promoters

37.79%

FII

0.00%

Other DII

0.01%

Retail and other

62.21%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

36.15

P/E

30.43

P/B

1.41

ROE

4.74%

D/E

0.01

ROCE

6.87%

Div. Yield

0.00%

EPS(TTM)

1.83

Turnover

1.25

EV/EBITDA

15.24

Net Margin

2.53%

Op. Margin

4.92%

ROA

3.65%

Quick Ratio

1.42

Curr. Ratio

2.46

Mkt Cap Cr

36.15

P/E

30.43

P/B

1.41

ROE

4.74%

D/E

0.01

ROCE

6.87%

Div. Yield

0.00%

EPS(TTM)

1.83

Turnover

1.25

EV/EBITDA

15.24

Net Margin

2.53%

Op. Margin

4.92%

ROA

3.65%

Quick Ratio

1.42

Curr. Ratio

2.46

Based on fundamentals, this stock's

Performance

Good

Sandu Pharma. outperforming most market indices

Valuation

Overvalued

Sandu Pharma. appears overvalued compared to its peers

Earnings

Neutral

Sandu Pharma. earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,48,196.00	36.51	5.29	13.74%	0.61	17.33%	93.24	0.86%	0.48	10.90
Divis Laboratories	2,50,390.00	84.81	14.80	15.32%	0.00	19.56%	629.49	0.32%	0.55	98.19
Torrent Pharmaceuticals	1,88,967.00	88.06	22.57	25.49%	1.69	13.85%	222.76	0.68%	0.49	58.70
Zydus Lifesciences	1,15,810.00	25.22	4.27	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,11,888.00	33.25	3.24	11.27%	0.00	14.95%	423.36	0.94%	0.45	43.52
Laurus Labs	1,08,338.00	99.36	20.44	16.77%	0.40	16.14%	97.20	0.10%	0.67	13.72
Mankind Pharma	1,00,364.00	49.53	6.28	11.74%	0.34	13.13%	396.98	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,329.00	31.78	2.66	11.07%	0.18	12.54%	377.95	0.66%	0.41	38.68
Aurobindo Pharma	98,803.90	26.31	2.58	9.25%	0.19	11.76%	394.82	0.24%	0.38	41.58
Lupin	96,950.00	17.47	4.32	23.76%	0.04	24.88%	658.96	0.85%	0.57	129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SANDU PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023
Revenue	₹67.19	₹67.28	₹65.35
Other Income	₹0.17	₹0.42	₹0.33
Total Revenue	₹67.36	₹67.70	₹65.68
Total Expenses	₹65.20	₹65.63	₹63.46
Profit Before Tax	₹2.16	₹2.07	₹2.22
Tax	₹0.61	₹0.61	₹0.70
Profit After Tax	₹1.55	₹1.46	₹1.52
EPS - Basic	₹1.60	₹1.51	₹1.62
EPS - Diluted	₹1.60	₹1.51	₹1.62

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹2.16	₹2.07	₹2.22
Income before WC changes	₹2.86	₹2.48	₹2.69
Change in Assets	-₹2.13	₹2.61	-₹3.99
Change in Liabilities	₹0.80	-₹3.83	₹2.21
Change in WC	-₹1.32	-₹1.22	-₹1.77
Cash flow from Operations	₹0.95	₹0.76	₹0.22
Cash flow from Investing	-₹0.19	-₹1.31	₹0.54
Cash flow from Financing	-₹0.46	-₹0.72	₹0.58
Total Cash Flow	₹0.30	-₹1.27	₹1.34
Cash (Start of the year)	₹1.00	₹2.28	₹0.94
Cash (End of the year)	₹1.30	₹1.00	₹2.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹29.42	₹30.11	₹28.62
Current Assets	₹26.30	₹22.30	₹25.55
Total Assets	₹55.72	₹52.41	₹54.17
Current Liabilities	₹12.09	₹10.64	₹13.88
Net Current Asset	₹14.21	₹11.66	₹11.66
Non-Current Liabilities	₹1.62	₹1.18	₹1.04
Equity Capital	₹42.02	₹40.59	₹39.24
Total Equity & Liabilities	₹55.72	₹52.41	₹54.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹69.93	₹67.19	₹67.28	₹65.35
Other Income	₹0.44	₹0.17	₹0.42	₹0.33
Total Revenue	₹70.38	₹67.36	₹67.70	₹65.68
Total Expenses	₹67.72	₹65.20	₹65.63	₹63.46
Profit Before Tax	₹2.66	₹2.16	₹2.07	₹2.22
Tax	₹0.89	₹0.61	₹0.61	₹0.70
Profit After Tax	₹1.77	₹1.55	₹1.46	₹1.52
EPS - Basic	₹1.83	₹1.60	₹1.51	₹1.62
EPS - Diluted	₹1.83	₹1.60	₹1.51	₹1.62

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹2.66	₹2.16	₹2.07	₹2.22
Income before WC changes	₹3.65	₹2.86	₹2.48	₹2.70
Change in Assets	₹3.10	-₹2.13	₹2.61	-₹3.99
Change in Liabilities	₹0.12	₹0.80	-₹3.83	₹2.21
Change in WC	₹3.22	-₹1.32	-₹1.22	-₹1.78
Cash flow from Operations	₹6.12	₹0.95	₹0.76	₹0.22
Cash flow from Investing	-₹0.57	-₹0.18	-₹1.31	₹0.53
Cash flow from Financing	-₹0.94	-₹0.46	-₹0.72	₹0.58
Total Cash Flow	₹4.60	₹0.31	-₹1.27	₹1.33
Cash (Start of the year)	₹1.30	₹1.00	₹2.27	₹0.94
Cash (End of the year)	₹5.91	₹1.30	₹1.00	₹2.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹30.55	₹29.42	₹30.12	₹28.63
Current Assets	₹25.32	₹26.30	₹22.30	₹25.54
Total Assets	₹55.87	₹55.72	₹52.42	₹54.17
Current Liabilities	₹10.42	₹12.09	₹10.64	₹13.88
Net Current Asset	₹14.90	₹14.21	₹11.66	₹11.66
Non-Current Liabilities	₹1.77	₹1.62	₹1.18	₹1.04
Equity Capital	₹43.67	₹42.02	₹40.60	₹39.24
Total Equity & Liabilities	₹55.87	₹55.72	₹52.42	₹54.17

* All values are in INR Crore

Qty

Bid

37.5

37.06

200

37.05

500

37.01

Ask

Qty

37.99

500

38.35

500

38.39

38.4

100

Bid Total: 772

Ask Total: 1120

Buy orders: 41%

Sell orders: 59%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bearish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

49.72

Neutral

ATR (14)

1.48

Neutral

STOCH(9,6)

81.27

Bearish

STOCH RSI (14)

70.39

Neutral

ADX(9)

28.27

Bearish

UO(9)

51.29

Neutral

ROC(12)

-3.48

Bearish

WillR(14)

-40.47

Neutral

Period

Simple value

Exponential vaue

37.08

37.34

10D

37.25

37.36

20D

37.59

37.6

50D

38.48

38.38

100D

39.91

38.78

Volume trend — traded volume by day
22 Sep	0L
21 Sep	0L
18 Sep	0L
17 Sep	0L
16 Sep	0L
Average	0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SANDU PHARMACEUTICALS LTD.

Pharmaceuticals

Add Stock

Add Another

Dividend

Ex-date: 04 Sep 2026

₹1/share

Top Gainers

MOTILALOFS Share Price

₹1055.20

+48.2 (+4.79%)

BALAMINES Share Price

Top Losers

Popular Stocks

Tata Steel Limited Share Price

TATASTEEL

₹187.54

+2.57 (1.39%)

Idfc First Bank Limited Share Price

IDFCFIRSTB

₹88.08

+2.71 (3.17%)

Tata Power Co Ltd Share Price

TATAPOWER

₹367.75

+0.75 (0.20%)

Trident Limited Share Price

TRIDENT

₹23.10

+0.17 (0.74%)

Indian Railway Fin Corp L Share Price

IRFC

₹80.50

+0.50 (0.63%)

Tata Motors Pass Veh Ltd Share Price

TMPV

₹300.30

+0.25 (0.08%)

Vodafone Idea Limited Share Price

IDEA

₹14.26

-0.01 (-0.07%)

Jio Fin Services Ltd Share Price

JIOFIN

₹231.90

+1.20 (0.52%)

Steel Authority Of India Share Price